Vivos Therapeutics VVOS
NASDAQ VVOS
$0.17 -0.01 (-5.38%)
As of: Sep 9, 2026 · 3:59 PM EDT

Vivos Therapeutics (VVOS) Revenue Growth (1y) (2021 - 2026)

Analysis

Vivos Therapeutics (VVOS) Revenue Growth (1y) (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (1y) (Qtr)
1 Align Technology 11.30 Bn 10.20 Bn 757.43 Mn 4.32%
2 Envista Holdings 4.38 Bn 3.26 Bn 407.00 Mn 7.10%
3 Dentsply Sirona 2.27 Bn 2.03 Bn 493.00 Mn -4.06%
4 Milestone Scientific 37.81 Mn 35.20 Mn 1.56 Mn -3.15%
5 Dror Ortho-Design 9.77 Mn 9.68 Mn - -
6 Vivos Therapeutics 2.76 Mn 790,007.20 2.95 Mn 34.90%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 34.90%
Mar 31, 2026 70.46%
Dec 31, 2025 3.41%
Sep 30, 2025 75.73%
Jun 30, 2025 -5.77%
Mar 31, 2025 -11.79%
Dec 31, 2024 13.85%
Sep 30, 2024 16.93%
Jun 30, 2024 19.41%
Mar 31, 2024 -11.36%
Dec 31, 2023 -17.77%
Sep 30, 2023 -22.26%
Jun 30, 2023 -18.86%
Mar 31, 2023 5.85%
Dec 31, 2022 -10.10%
Sep 30, 2022 -6.60%
Jun 30, 2022 -6.96%
Mar 31, 2022 5.68%
Dec 31, 2021 32.88%
Sep 30, 2021 38.11%